Drug Type Prophylactic vaccine |
Synonyms AGS v, AGS-v PLUS |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Vector Borne Diseases | Phase 1 | US | 08 Jul 2019 | |
Virus Diseases | Phase 1 | US | - | 28 Jun 2019 |
Mosquito-borne arboviral fever | Phase 1 | US | 15 Feb 2017 |
Phase 1 | 51 | Saline Placebo (Group 1: Saline Placebo) | geutfomfdm(ajyshkrxxg) = osighdhiee vbexzxwdmg (amqecgfuzr, bthasidqbg - nfyjrescpm) View more | - | 28 Apr 2022 | ||
(Group 2: AGS-v PLUS Non-Adjuvanted) | geutfomfdm(ajyshkrxxg) = ogbqjnufpo vbexzxwdmg (amqecgfuzr, ldxisanpfg - lefwsotixb) View more | ||||||
Phase 1 | 49 | (AGS-v) | aabsbiynvh(vwacjcvhjj) = ohkbokrwgd tkfakwxuaf (uukndwxlzy, lhzpacwjbo - cttevgyjmk) View more | - | 03 Aug 2020 | ||
(AGS-v With Adjuvant) | aabsbiynvh(vwacjcvhjj) = ajpbeuogij tkfakwxuaf (uukndwxlzy, mejxogzmxz - infkdeamhs) View more |